5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde CAS 881674-56-2 Vonoprazan Fumarate Intermediate Purity ≥99.0%

Lus piav qhia luv luv:

Lub npe: 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde

CAS: 881674-56-2 Nr

Purity: ≥99.0%

Cov tsos mob: daj rau xim av hmoov

Intermediate ntawm Vonoprasan Fumarate (CAS: 1260141-27-2)

High Quality, Commercialized Production

Inquiry: alvin@ruifuchem.com


Product Detail

Yam khoom

Khoom cim npe

Nqe lus piav qhia:

Chemical Properties:

Tshuaj npe 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde
Synonyms Vonoprazan Fumarate (TAK-438) Nruab nrab 3
CAS Nr 881674-56-2
CAT Number Qauv: RF-PI330
Tshuag xwm txheej Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons
Molecular Formula C11H8FNO
Molecular Luj 189.19 Nws
Hom Ruifu Tshuaj

Specifications:

Yam khoom Specifications
Qhov tshwm sim Yellow rau Brown hmoov
Melting Point 122.0 ~ 131.0 ℃
Kev txheeb xyuas: RT (HPLC) Ua Raws Li Cov Qauv Siv
Poob Thaum Qhuav ≤0.50%
Residue ntawm Ignition ≤0.50%
Yam khoom muaj feem
Purity ≥99.0%
Ib qho Impurity ≤0.50%
Tag nrho cov impurities ≤ 1.0%
Test Standard Enterprise Standard
Kev siv Intermediate ntawm Vonoprasan Fumarate (TAK-438) (CAS 881681-01-2)

Pob & Cia:

Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.

Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.

Qhov zoo:

1

FAQ:

Daim ntawv thov:

5-(2-Fluorophenyl)-1H-Pyrrole-3-Carbaldehyde (CAS 881674-56-2) ua raws li cov tshuaj reagent nyob rau hauv cov hluavtaws npaj ntawm cov tshiab pyrrole derivatives li potassium-competitive acid blocker (P-CAB).5-(2-Fluorophenyl)pyrrole-3-Carboxaldehyde yog qhov nruab nrab ntawm Vonoprasan Fumarate (CAS 1260141-27-2).Vonoprazan fumarate (Takecab®), nrhiav pom thiab tsim los ntawm Takeda thiab Otsuka, tau pom zoo los ntawm PMDA ntawm Nyiv thaum Lub Kaum Ob Hlis 2014, thiab tau qhia rau kev kho mob plab hnyuv, duodenal ulcer thiab reflux esophagitis.Vonoprazan fumarate muaj cov txheej txheem tshiab ntawm kev ua hu ua potassium-competitive acid blockers, uas muaj kev sib tw tiv thaiv kev khi ntawm cov poov tshuaj ions rau H +, K +-ATPase (tseem hu ua lub twj tso kua mis proton) hauv cov kauj ruam kawg ntawm gastric acid secretion hauv parietal hlwb.Vonoprazan tsis inhibit Na +, K +-ATPase kev ua haujlwm txawm tias nyob rau hauv ntau dua 500 npaug siab dua li ntawm lawv cov txiaj ntsig IC50 tawm tsam plab H +, K +-ATPase kev ua haujlwm.Tsis tas li ntawd, cov tshuaj tsis cuam tshuam los ntawm lub plab zais zis, tsis zoo li PPIs.

Sau koj cov lus ntawm no thiab xa tuaj rau peb